The  cGMP  Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction | Zendy

Greene Stephen J. | Zendy; Gheorghiade Mihai | Zendy; Borlaug Barry A. | Zendy; Pieske Burkert | Zendy; Vaduganathan Muthiah | Zendy; Burnett John C. | Zendy; Roessig Lothar | Zendy; Stasch JohannesPeter | Zendy; Solomon Scott D. | Zendy; Paulus Walter J. | Zendy; Butler Javed | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction

Author(s) -

Greene Stephen J.,

Gheorghiade Mihai,

Borlaug Barry A.,

Pieske Burkert,

Vaduganathan Muthiah,

Burnett John C.,

Roessig Lothar,

Stasch JohannesPeter,

Solomon Scott D.,

Paulus Walter J.,

Butler Javed

Publication year - 2013

Publication title -

journal of the american heart association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.494

H-Index - 85

ISSN - 2047-9980

DOI - 10.1161/jaha.113.000536

Subject(s) - medicine , heart failure , ejection fraction , cardiology , heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction (HFpEF) is a growing public health problem that accounts for approximately half of all prevalent heart failure (HF).[1][1]–[2][2] Once believed to carry a favorable prognosis compared with HF and reduced ejection fraction (HFrEF), contemporary data

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research